Global Point-of-Care Infectious Disease Diagnostics/Testing Market Segmentation, Demand and Supply 2019

According to a new report by IMARC Group titled, “Blood Culture Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global blood culture test market grew at a CAGR of around 9% during 2014-2019.A blood culture test is conducted to diagnose bacterial, fungal, and mycobacterial infections in the blood.

It identifies various microorganisms in the blood sample and prevents the development of sepsis.

The culture test helps in determining typical pathogens in the blood and possible ways to treat them.

It utilizes blood culture media, assay kits, reagents, automated blood culture systems, and supporting laboratory equipment.Market TrendsThe sudden outbreak of COVID-19 has predominantly catalyzed the demand for blood culture tests to combat disease transmission.

Several medical laboratories, diagnostic centers, and other healthcare facilities are widely adopting these tests to identify the presence of antibodies in the blood and isolate the infected individuals.

The rising geriatric population, along with the growing consumer health concerns towards the high prevalence of infectious diseases, is further bolstering the market growth.

This growth in the market is the move from categorized laboratory to decentralized treatment research laboratory.Growing incidence of infectious diseases, surge in the grants from numerous government and private organizations and rising demand for new diagnostic tests to monitor infectious diseases is the major driver that will impact this market growth in the forecast period to 2027.Infectious disease diagnosis relates to the screening or evaluation of the involvement of any infectious organisms in the skin.

There are increasing demands in hospitals, clinical laboratories, referral laboratories, government agencies and research institutes for the testing of infectious disease among the population.Factor that restraint the growth of the market such as the rigorous regulatory approval process for contagious diagnostic instruments, the advancement of molecular techniques and adverse reimbursement scenariosNorth America infectious disease diagnostics market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market.

To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.Get Exclusive PDF Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-infectious-disease-diagnostics-marketNorth America Infectious Disease Diagnostics Market Scope and Market SizeNorth America Infectious disease diagnostics market is segmented of the basis of product & service, technology, disease type, end user.

The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.Based on product & service the infectious disease diagnostics market is segmented into Assays, Kits, & Reagents, Instruments, Services & Software.based on technologyInfectious disease diagnostics market, is segmented into immunodiagnostics, clinical microbiology, biochemical characterization, polymerase chain reaction (pcr), isothermal nucleic acid amplification technology (inaat), dna sequencing & next-generation sequencing (ngs), dna microarray, hybridization, mass spectroscopy, other.based on disease type Infectious disease diagnostics market, is segmented into hepatitis, acquired immunodeficiency syndrome (aids), human immunodeficiency virus (hiv), chlamydia trachomatis genital infection and gonorrhea (ct/ng), hospital-acquired infections (hais), human papillomavirus (hpv), tuberculosis (tb) influenza, other.By the end user the Infectious disease diagnostics market is segmented into hospital/clinical laboratories, reference laboratories, physician offices, academic/research institutes, other.Know more about this report https://www.databridgemarketresearch.com/reports/north-america-infectious-disease-diagnostics-marketCompetitive Landscape and North America Infectious Disease Diagnostics Market Share AnalysisNorth America Infectious disease diagnostics market competitive landscape provides details by competitor.

Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve.

The above data points provided are only related to the companyies focus related to North America infectious disease diagnostics market.The major players covered in the North America infectious disease diagnostics market are Abbott, BD, bioMérieux SA, Danaher, F. Hoffmann-La Roche Ltd, Meridian Bioscience Inc., QIAGEN, Accelerate Diagnostics, Inc., Bio-Rad Laboratories, Inc., DiaSorin Molecular LLC., Luminex Corporation., OpGen, Inc., Quidel Corporation., Thermo Fisher Scientific Inc., Thermo Fisher Scientific Inc., Bruker, Eurofins Scientific, Hologic, Inc., Immunexpress Inc., Response Biomedical Corp., Seegene Inc., T2 Biosystems, Inc. among other domestic players.

Point of Care (POC) diagnostics are tests that are designed to be used near the patient site which do not require a dedicated permanent area and are conducted outside clinical spaces.

The major drivers of this market include increased aging population, immediate test results and rising market penetration of EMR (Electronic Medical Records) and PACS (Picture Archiving and Communication Systems).

Additionally, shortage of skilled staff at the diagnostics facilities is expected to aid POC market penetration and positioning.

Out-care patient model which is an initiative taken by the governments to reduce stay in the hospitals along with homecare and other health care facilities are expected to help in promoting POC diagnostics.

POC diagnostics have initiated a decentralized trend in the healthcare industry which facilitates patients to be catered at remote locations, get early diagnostics and reduce costs.Adaptation of automated laboratory systems and highly integrated solutions facilitate the diagnostic workflow, which in turn drives adoption of point of care diagnostic/testing products.

Lack of skilled professionals or medical personnel with limited training especially in diagnostics can also easily use these devices.Rise in R activities among key players to introduce novel POC tests and devices for rapid disease detection and monitoring is expected to fuel industrial progression.

Reports and Data has recently published a new research report on Global Transplant Diagnostics  Market that covers current development scenario and emerging trends of the market.

The research report provides a comprehensive assessment of the market size, market share, revenue growth, and provides a futuristic perspective about the market trends, growth factors, facts, and industry validated market data.

The report applies advanced statistical tools such as Porter’s Five Forces analysis and SWOT analysis to shed light on the competitive landscape of the global Transplant Diagnostics  market.

The report covers all the critical and essential information relating to the global Transplant Diagnostics  market which helps the readers and clients gain a thorough understanding of the market.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4039The report initially offers market introduction, market overview, product scope, market opportunities, growth prospects, risks, limitations, and key drivers.

The report also covers a comprehensive analysis of the competitive landscape with extensive profiling of the key competitors.

It covers recent technological advancements, product developments, product launches, mergers and acquisitions, collaborations, joint ventures, and partnerships.Key Companies in the market include: Hoffmann-La Roche, Thermo Fisher Scientific Inc., Immucor Transplant Diagnostics, Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories, Qiagen N.V., BioMérieux SA, Illumina, Inc., GenDx, Omixon Ltd., Affymetrix, Inc., CareDx, Luminex Corporation, Takara Bio, Becton, Dickinson and Company, Hologic Inc., CareDx, Biofortuna, and BAG Healthcare Regional segmentation comprises of a current and forecast estimation of the market in the key geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

According to a new study published by Polaris Market Research the worldwide blood testing market is anticipated to reach USD 65,464.3 million by 2026.

In 2017, the glucose testing segment dominated the global market, in terms of revenue, whereas geographically, North America accounted for the majority share in the global blood testing market.

Use of self-testing products and home diagnostic tests, blood testing in under-developed countries, and research and development for developing new testing technologies further provide growth opportunities for the blood testing market in the forecast period.

Request for a sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/blood-testing-market/request-for-sample In the era of rapid and effective medical treatments, physicians and other medical personnel are dependent on various types of laboratory testing in order to make an accurate diagnosis and carry out subsequent treatment measures.

Furthermore, the elderly population undergoes complex surgical procedures such as dialysis, joint replacements and cancer therapies which requires blood transfusions.

These factors are anticipated to bolster the demand for blood testing in the upcoming years.

Antimicrobial Susceptibility Testing Market is comprehensive and accurately presented in the report with the help of detailed market information and data, critical findings, error-free statistics, and reliable forecasts.

The report digs deep into important aspects of the global Antimicrobial Susceptibility Testing market, including competition, segmentation, regional expansion, and market dynamics.

Each leading trend of the global Antimicrobial Susceptibility Testing market is carefully studied and elaborately presented in the report.

Readers are also provided with detailed information on key drivers and restraints of the global Antimicrobial Susceptibility Testing market.

Players can become informed about unknown future challenges in the global Antimicrobial Susceptibility Testing market and prepare effective strategies to better deal with them.The antimicrobial susceptibility testing market is expected to gain market growth in the forecast period of 2021 to 2028.

Data Bridge Market Research analyses that the market is growing with a CAGR of 5.7% in the forecast period of 2021 to 2028 and is expected to reach USD 5,346.34 million by 2028.Note - Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Antimicrobial Susceptibility Testing Market which would mention How the Covid-19 is affecting the Antimicrobial Susceptibility Testing Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Antimicrobial Susceptibility Testing Players to Combat Covid-19 Impact.Get Latest Sample for Antimicrobial Susceptibility Testing Market Report (including COVID19 Impact Analysis) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-antimicrobial-susceptibility-testing-marketAntimicrobial Susceptibility Testing Market Country Level AnalysisThe antimicrobial susceptibility testing market is analysed and market size information is provided by the country, product type, methods, type, application, end user and distribution channel as referenced above.The countries covered in the antimicrobial susceptibility testing report are the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa and among others.

The study involved four major activities in estimating the current size of the transplant diagnostics market.

Exhaustive secondary research was conducted to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the total market size.According to the new market research report ”Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (Hospital) – Global Forecast to 2025“, published by MarketsandMarkets™,  transplant diagnostics market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%.Major Growth Drivers:The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing burden of infectious diseases, the increasing number of transplant procedures, and technological advancements in the field of transplant diagnostics.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=2531061Expected Revenue Growth:[227 Pages Report] The transplant diagnostics market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%.An analysis of the market developments between 2016 and 2019 revealed that product launches & enhancements, partnerships, agreements, and acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the market.

Product launches were the most widely adopted growth strategies.The molecular assay technologies segment accounted for the largest share of the transplant diagnostics market, by technology, in 2019The market, by technology, is segmented into molecular and non-molecular assay technologies.

In 2019, the molecular assay technologies segment accounted for the largest share of the market.

According to Trends Market Research, the Global In-Vitro Diagnostics Market was valued at $67,111 million in 2019, and is projected to reach $91,093 million at a CAGR of 4.8% from 2020 to 2027.

The report analyses the global In Vitro Diagnostics Market, the market size and growth, as well as the major market participants.The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment.

In addition, the report outlines the factors driving industry growth and the description of market channels.

The report begins from overview of industrial chain structure, and describes the upstream.

Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.Key Market SegmentsBy Product & ServiceReagentsInstrumentsSoftware and ServicesGet An Exclusive Sample Of the Research Report at: https://www.trendsmarketresearch.com/report/sample/13511 By TechniqueImmunodiagnosticsEnzyme-Linked Immunosorbent Assay (ELISA)Chemiluminescence Immunoassay (CLIA)Fluorescence immunoassay (FIA)    Colorimetric Immunoassay (CI)Rapid TestsEnzyme-Linked ImmunoSpot (ELISPOT)    Radioimmunoassay (RIA)Western BlotHematologyMolecular DiagnosticsPolymerize Chain Reaction (PCR)Isothermal Nucleic Acid Amplification Technology (INAAT)HybridizationDNA diagnosticsMicroarrayOthersTissue DiagnosticsClinical ChemistryBasic Metabolic PanelLiver PanelLipid ProfileThyroid Function PanelElectrolyte Panel    Specialty ChemicalsOthersBy ApplicationInfectious DiseasesCancerCardiac DiseasesImmune System DisordersNephrological Diseases Gastrointestinal DiseasesOthersBy End User Standalone LaboratoriesHospitalsAcademic & Medical SchoolsPoint-of-CareOthersBuy Now report with Analysis of COVID-19 at: https://www.trendsmarketresearch.com/checkout/13511/Single By RegionNorth AmericaU.S.CanadaMexicoEuropeUKGermanyFranceItalyRest of EuropeAsia-PacificChina IndiaJapanRest of Asia-PacificLAMEALatin AmericaMiddle East AfricaKey playersThe global in vitro diagnostics market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum in vitro diagnostics market share.

These include collaboration, product launch, partnership, and acquisition.

Market Analysis: Global Companion Diagnostics MarketCompanion diagnostics market is growing at a healthy CAGR of 22.50% during the forecast period of 2019 to 2026.

The growth in the market is attributed to the rising of chronic diseases, growing demand for personalized medicine and growing adoption of companion diagnostics.Global Companion Diagnostics Market By Product and Services (Assay Kits and Reagents, Software & Services), Technology (Polymerase Chain Reaction, Molecular Diagnostics, FISH, CISH, Immunohistochemistry, Real-time PCR, Next-Generation Sequencing, Gene Sequencing, In Situ Hybridization), Application (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, Urology, Gastric Cancer), Indication (Oncology {Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma} Neurology, Infectious Diseases), End Users (Pharmaceutical and Biopharmaceutical Companies, Reference Laboratories), Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa)– Industry Trends and Forecast to 2026 - Industry Trends and Forecast to 2026Download Sample Report with related Graphs and Figures@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-companion-diagnostics-marketMarket Definition: Global Companion Diagnostics MarketA companion diagnostic is a medical device, used as in- vitro device, which gives information about safety and effectiveness of drug.

Increasing number of genetic testing is enhancing the market growth.Market Drivers·       Increasing number of genetic testing is enhancing the market growth·       Improvements in regulatory guidelines drive the market growth·       Growing need for targeted therapies is flourishing the market growth·       Rising cancer incidence worldwide acts as a catalyst for the market growthMarket Restraints·       Increase in cost related to technological advancement is hampering the market growth·       Reimbursement issues among many countries is restraining the marketClick here for Detailed Analysis Report@ https://www.databridgemarketresearch.com/reports/global-companion-diagnostics-marketCompetitive Analysis:Global companion diagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.

The report includes market shares of companion diagnostics market for global Europe, North America, Asia-Pacific, South America and Middle East & Africa.Key Market Competitors:Some of the major players operating in global companion diagnostics market are F. Hoffmann-La Roche Ltd., Qiagen, Abbott, Almac Group, Agilent Technologies, Inc., Clinical Lab Products, Myriad Genetics, Inc., Leica Biosystems Nussloch GmbH, Resonance Health, ARUP Laboratories, Life Technologies Tm, Sysmex Corporation, Thermo Fisher Scientific Inc., Illumina, Inc., Hologic, Inc., Abnova Corporation, bioMérieux SA, Siemens Healthcare Private Limited among others.Get Access Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-companion-diagnostics-marketResearch Methodology- Global Companion Diagnostics MarketData collection and base year analysis is done using data collection modules with large sample sizes.

Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the research methodology, drop in an inquiry to speak to our industry experts.Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-companion-diagnostics-marketKey Developments in the Market:In May 2019, QIAGEN received approval on Piqray and fulvestrant combination, which helped to diagnose cancer in the patient.

To thrive in this competitive age, business should get knowledgeable about the major accomplishments taking place in the market.

Market research analysis and all the information lends a hand to businesses for the planning of production, product launches, costing, inventory, purchasing and marketing strategies.

To get success in this competitive market place, Systemic Lupus Erythematosus Treatment market research report plays a vital role which provides important and meaningful market insights for any business in the Systemic Lupus Erythematosus Treatment industry.

Choosing such market research report is all the time beneficial for any company, whether it is a small scale or large scale, for marketing its products or services.Systemic lupus erythematosus market is expected to gain market growth in the forecast period of 2020 to 2027.

Data Bridge Market Research analyses the market to account to USD 3.70 billion by 2027 growing at a CAGR of 7.05% in the above-mentioned forecast periodThe report analyses and estimates general market drivers in the form of consumer demand, government policy and demand which are related to consumer buying pattern, market growth and development.

A team containing domain experts analyses and estimates this market data using well established market statistical and coherent models.

Market Analysis and Insights:- Global PCR Multiplex Assays MarketGlobal PCR Multiplex Assays Market By Products & Services (Reagents & Consumables, Instruments & Accessories, Software and Services), Applications (Clinical Diagnostics, Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) -  Industry Trends & Forecast to 2026Multiplex assays are the new technology which is incorporated with the capability to run more than one target sequence in a single step, the evolution of the PCR multiplex assays in terms of smart features with voice command, facial authentication and radio-frequency identification (RFID) features changes from an manual instrument to an automated PCR multiplexes systems in the year 2016 to 2018.Multiplex assay can amplify more than one target sequence with the help of multiple primer pairs in reaction mixtures.

The PCR technique is a time saving with significant less efforts in the laboratory experiments, which is a convenient and rapid screening assay for clinical and research laboratories.

The PCR multiplex assay manufactures to expand their business for the development of services.

The introduction of product helps clinicians in microbial profiling and expanded the advanced product portfolio of the company.Global PCR multiplex assays market is projected to register a CAGR of 7.2% in the forecast period of 2019 to 2026.Get More Insights About the Global PCR Multiplex Assays Market, Request Sample@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-pcr-multiplex-assays-marketSegmentation: Global PCR Multiplex Assays MarketGlobal PCR multiplex assays market is segmented into three notable segments which are products & services, application and end user.On the basis of products & services, the market is segmented into reagents & consumables, instruments & accessories and software and services.In June 2017, Bio-Rad Laboratories, Inc. launched a RT-PCR kit which allows researchers to screen samples for dengue (DENV1, DENV2, DENV3, DENV4), Zika (ZIKV) and chikungunya (CHIKV) arbovirus RNAs.

The assays comprise the controls which researchers needs for the validation of results.

The launch of the products helps researchers to rely on wet-lab validated tool and helps manufacturers in GMP-approved facilities to obtain consistent results.On the basis of application, the market is segmented into research & development and clinical diagnostics.Know more about this https://www.databridgemarketresearch.com/reports/global-pcr-multiplex-assays-marketIn November 2018, Biomérieux SA, Inc. announced the acquisition of Suzhou Hybiome Biomedical Engineering Co. Ltd. (China).

The market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global microbial identification market.

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects.

The size of the Microbial identification services market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10702182Major Market Growth Drivers: Growth in Microbial Identification Market is largely driven by the rising incidence of infectious diseases and the increasing frequency of pandemics, technological advancements, increasing food safety concerns, and increasing government initiatives and funding to detect and control antimicrobial-resistant species.Revenue Growth Analysis: [220 Pages Report] The global microbial identification market size is estimated to be USD 3.2 billion in 2020 and projected to reach USD 5.7 billion by 2025, at a CAGR of 12.2%.Browse and in-depth TOC on" Microbial Identification Market"261 – Tables 33 – Figures 220 – Pages By the consumables segment, the panels/ID cards & media segment accounted for the largest share of the microbial identification market in 2019.

On the basis of product & service type, the consumables market is segmented into panels/ID cards & media, kits and other consumables.

In 2019, panels/ID cards & media accounted for the largest share of the consumables segment.

Panels, ID cards, and media enable the easy and rapid identification of microorganisms and is a key factors driving market growth Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=10702182By technology, the mass spectrometry segment accounted for the largest share of the microbial identification market in 2019.

Global Life Science Reagents Market was valued US$ 30 Bn in 2017 and expected to reach US$ 60 Bn by 2026, at a CAGR of 9.5% during forecast period.

On the basis of product, the market is divided into polymerase chain reaction (PCR) reagent kits, cell and tissue culture reagents, flow cytometry reagents, electrophoresis reagents, chromatography reagents, in-vitro diagnostics (IVD) reagents, others (gene expression reagents, mass spectroscopy reagents, and transfection reagents).

The life science and analytical reagents market is driven by the increasing use of reagents in basic research, therapeutics, and commercial applications.

The biotechnology instrumentation market continues to witness important growth because of an increase in the number of biotechnology firms and rises in research and development spending by biotechnology companies, thus boosting the demand for biotechnology instruments.

Well-established health care infrastructure, the large base of pharmaceutical and biotechnology industries, rapidly growing geriatric population has led to dominant shares of North America and Europe.

Key players operated in life science reagents market are life technologies, bio-rad, thermo fisher scientific, water corporation, Sigma-Aldrich, Agilent technologies inc., betcon Dickinson, Beckman colter, Abbott (u.s.), ortho clinical diagnostics, biomérieux sa, Sysmex Corporation, and diasorin s.p.a., f. Hoffmann-la Roche ag, Danaher Corporation, Siemens healthiness (siemens ag), Merck kgaa, ge healthcare, bio-techne corp, Bruker Corp, Perkin Elmer inc., Qiagen n.v., (includes bd life sciences), Illumina inc., Roche, Promega corp., Beckman coulter, inc., biomerieux, inc., Lonza group ltd., Merck Millipore, meridian life science, Inc.This Report Is Submitted By @Maximize Market Research CompanyCustomization of the report:Maximize Market Research provides free personalized of reports as per your demand.

Rising prevalence of infectious diseases globally is driving revenue growth of the market Market Size – USD 8.2 Billion in 2020, Market Growth – at a CAGR of 4.6%, Market Trends –Growing demand for point-of-care testing productsThe Global Lateral Flow Assays Market size is expected to reach USD 11.66 billion by 2028 at a CAGR of 4.6%, according to the latest report by Reports and Data.

Rising consumption rate for home-based lateral flow testing solutions and products, and growing requirement of better point-of-care testing products are a few major factors driving the revenue growth of the lateral flow assays market.

Lateral flow assay involves antibodies and probe DNA biochemical interaction.

This diagnostic method ensures simplified test with low costs and no requirement of any interference while the test is being conducted.

Moreover, the test can also be easily conducted by non-trained individuals due to its highly user-friendly form of testing.Increasing geriatric population leads to rising prevalence of different types of infectious diseases across the globe, which is one of the most crucial factors expected to propel the revenue growth of the lateral flow assays market during the forecasted period.Ask for Sample Report @ https://www.reportsanddata.com/sample-enquiry-form/4086However, lack of preference from consumers to shift from conventional diagnostic testing methods and adopting advanced methods is one of the significant factors predicted to restrain the market revenue growth to a certain extent between 2021 & 2028.Further key findings in the reportThe clinical testing segment is expected to hold largest revenue share in the market during the forecast period due to its significance in disease detection along with a sharp rise in the incidence of different types of infectious diseases.

The food safety & environment testing segment is predicted to register highest revenue share in the lateral flow assays market going ahead.